MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
Clinical trial NCT02285816 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02285816
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-22
- Primary completion
- 2019-09-19
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.